A 55-year-old male presents with blood in his urine. Urinalysis shows 2+ blood and 2 red blood cells per high-powered field. The patient's history of smoking increases his risk for urinary tract malignancy. The appropriate initial step is to repeat the urinalysis and urine microscopic to confirm if the patient meets the criteria for microscopic hematuria of 3 or more red blood cells per high-powered field on two properly collected urine specimens. Further evaluation including imaging of the urinary tract should be considered given the patient's risk factors.
Sickle cell nephropathy (SCN) is presence of sickled erythrocytes in the renal medulla that result in decreased medullary blood flow, ischemia, microinfarcts and papillary necrosis in the kidneys
1. Acute pyelonephritis is a sudden, severe bacterial infection of the kidneys that commonly affects young women. It is caused by bacteria like E. coli traveling from the bladder to the kidneys.
2. Symptoms include fever over 102°F, flank pain, painful or frequent urination, and other urinary symptoms. Risk factors include female anatomy, kidney stones, diabetes, and other underlying conditions.
3. Diagnosis involves urine and blood tests showing white blood cells and bacteria. Imaging tests can confirm infection in the kidneys. Treatment consists of intravenous or oral antibiotics like ciprofloxacin or trimethoprim/sulfamethoxazole for 5-14 days.
1) Alcoholic hepatitis is caused by chronic excessive alcohol ingestion and can lead to fatty liver, alcoholic hepatitis, or alcoholic cirrhosis. Risk increases with more than 60-80 g of alcohol per day for 10 years in men or 20-40 g per day for 10 years in women.
2) Alcoholic hepatitis presents with fever, jaundice, abdominal pain, and muscle wasting. Liver tests show elevated AST and ALT levels and AST:ALT ratio over 2. Treatment involves alcohol abstinence, nutrition support, corticosteroids or pentoxifylline, and liver transplantation may be considered.
3) Drug-induced hepatitis can occur through direct toxicity or idiosyncratic reactions.
This document discusses chronic complications of diabetes mellitus, focusing on microvascular complications including retinopathy, nephropathy, neuropathy, and foot disease as well as macrovascular complications affecting the coronary, cerebral, and peripheral circulations. It provides details on the pathogenesis, risk factors, diagnosis, and management of diabetic retinopathy and nephropathy. It also covers diabetic neuropathy, including different types, clinical features, and treatments. The document concludes with a discussion of diabetic foot complications including foot ulcers and Charcot neuroarthropathy.
A 3-year-old boy presented with puffy eyes and edema. Examination found pitting edema, elevated heart rate, and proteinuria. Tests showed normal kidney and liver function. He was diagnosed with nephrotic syndrome based on his symptoms and urine protein level. Nephrotic syndrome is characterized by protein in the urine and symptoms of edema, low albumin, and high cholesterol or lipids. The majority of cases in children are idiopathic and due to minimal change disease. Treatment involves supportive care, steroids, and other medications depending on response and side effects.
Uremic encephalopathy occurs when toxins that are normally cleared by the kidneys build up in the bloodstream due to kidney failure. It causes a range of neurological symptoms from mild issues like fatigue to severe problems like seizures and coma. The condition develops when kidney function declines to the point that creatinine clearance levels fall below 15 mL/min. While the exact cause is unknown, it involves the accumulation of various toxins in the brain that disrupts cell metabolism and function. Prompt treatment with dialysis or kidney transplantation can reverse the neurological symptoms.
This document discusses the approach to hematuria in children. It begins by defining hematuria and describing different types. It then outlines the most common etiologies of glomerular and non-glomerular hematuria. The document emphasizes taking a thorough history and physical exam. It recommends investigations including urine analysis, culture and microscopy, blood tests, imaging and potentially renal biopsy. Based on the cause, management may include reassurance, antibiotics, supportive care, monitoring, correcting complications, surgery or dialysis. The document provides a helpful algorithm for evaluating and managing hematuria in children.
Hemolytic uremic syndrome (HUS) is a thrombotic microangiopathy characterized by thrombocytopenia, acute renal impairment, and microangiopathic hemolytic anemia. It has typical and atypical variants, with the typical variant caused by Shiga toxin-producing E. coli. HUS presents with varied symptoms depending on etiology and can progress to end-stage renal disease if left untreated. Treatment involves supportive care, dialysis if needed, and addressing the underlying cause. Outcomes depend on prompt diagnosis and intervention to prevent complications.
Sickle cell nephropathy (SCN) is presence of sickled erythrocytes in the renal medulla that result in decreased medullary blood flow, ischemia, microinfarcts and papillary necrosis in the kidneys
1. Acute pyelonephritis is a sudden, severe bacterial infection of the kidneys that commonly affects young women. It is caused by bacteria like E. coli traveling from the bladder to the kidneys.
2. Symptoms include fever over 102°F, flank pain, painful or frequent urination, and other urinary symptoms. Risk factors include female anatomy, kidney stones, diabetes, and other underlying conditions.
3. Diagnosis involves urine and blood tests showing white blood cells and bacteria. Imaging tests can confirm infection in the kidneys. Treatment consists of intravenous or oral antibiotics like ciprofloxacin or trimethoprim/sulfamethoxazole for 5-14 days.
1) Alcoholic hepatitis is caused by chronic excessive alcohol ingestion and can lead to fatty liver, alcoholic hepatitis, or alcoholic cirrhosis. Risk increases with more than 60-80 g of alcohol per day for 10 years in men or 20-40 g per day for 10 years in women.
2) Alcoholic hepatitis presents with fever, jaundice, abdominal pain, and muscle wasting. Liver tests show elevated AST and ALT levels and AST:ALT ratio over 2. Treatment involves alcohol abstinence, nutrition support, corticosteroids or pentoxifylline, and liver transplantation may be considered.
3) Drug-induced hepatitis can occur through direct toxicity or idiosyncratic reactions.
This document discusses chronic complications of diabetes mellitus, focusing on microvascular complications including retinopathy, nephropathy, neuropathy, and foot disease as well as macrovascular complications affecting the coronary, cerebral, and peripheral circulations. It provides details on the pathogenesis, risk factors, diagnosis, and management of diabetic retinopathy and nephropathy. It also covers diabetic neuropathy, including different types, clinical features, and treatments. The document concludes with a discussion of diabetic foot complications including foot ulcers and Charcot neuroarthropathy.
A 3-year-old boy presented with puffy eyes and edema. Examination found pitting edema, elevated heart rate, and proteinuria. Tests showed normal kidney and liver function. He was diagnosed with nephrotic syndrome based on his symptoms and urine protein level. Nephrotic syndrome is characterized by protein in the urine and symptoms of edema, low albumin, and high cholesterol or lipids. The majority of cases in children are idiopathic and due to minimal change disease. Treatment involves supportive care, steroids, and other medications depending on response and side effects.
Uremic encephalopathy occurs when toxins that are normally cleared by the kidneys build up in the bloodstream due to kidney failure. It causes a range of neurological symptoms from mild issues like fatigue to severe problems like seizures and coma. The condition develops when kidney function declines to the point that creatinine clearance levels fall below 15 mL/min. While the exact cause is unknown, it involves the accumulation of various toxins in the brain that disrupts cell metabolism and function. Prompt treatment with dialysis or kidney transplantation can reverse the neurological symptoms.
This document discusses the approach to hematuria in children. It begins by defining hematuria and describing different types. It then outlines the most common etiologies of glomerular and non-glomerular hematuria. The document emphasizes taking a thorough history and physical exam. It recommends investigations including urine analysis, culture and microscopy, blood tests, imaging and potentially renal biopsy. Based on the cause, management may include reassurance, antibiotics, supportive care, monitoring, correcting complications, surgery or dialysis. The document provides a helpful algorithm for evaluating and managing hematuria in children.
Hemolytic uremic syndrome (HUS) is a thrombotic microangiopathy characterized by thrombocytopenia, acute renal impairment, and microangiopathic hemolytic anemia. It has typical and atypical variants, with the typical variant caused by Shiga toxin-producing E. coli. HUS presents with varied symptoms depending on etiology and can progress to end-stage renal disease if left untreated. Treatment involves supportive care, dialysis if needed, and addressing the underlying cause. Outcomes depend on prompt diagnosis and intervention to prevent complications.
The document discusses acute kidney injury (AKI), including its causes, diagnosis, and management. It provides details on prerenal, intrinsic, and postrenal forms of AKI. For prerenal AKI, management focuses on correcting the underlying cause, such as volume depletion, and restoring intravascular volume through fluid resuscitation. For intrinsic AKI, identifying and removing nephrotoxic agents is important. Dialysis may be needed for severe AKI with fluid/electrolyte imbalance or uremia.
Dr. Sachin Verma is a young, diligent and dynamic physician. He did his graduation from IGMC Shimla and MD in Internal Medicine from GSVM Medical College Kanpur. Then he did his Fellowship in Intensive Care Medicine (FICM) from Apollo Hospital Delhi. He has done fellowship in infectious diseases by Infectious Disease Society of America (IDSA). He has also done FCCS course and is certified Advance Cardiac Life support (ACLS) and Basic Life Support (BLS) provider by American Heart Association. He has also done a course in Cardiology by American College of Cardiology and a course in Diabetology by International Diabetes Centre. He specializes in the management of Infections, Multiorgan Dysfunctions and Critically ill patients and has many publications and presentations in various national conferences under his belt. He is currently working in NABH Approved Ivy super-specialty Hospital Mohali as Consultant Intensivists and Physician.
Hematuria for undergraduates
this is a presentation i prepared for medical students about hematuria, hope u like it
for more urology resources visit:
www.uronotes2012.blogspot.com
This document discusses alcoholic liver disease (ALD). It notes that ALD ranges in severity from fatty liver to alcoholic hepatitis to cirrhosis. Risk factors include the amount of alcohol consumed daily and genetically. Diagnosis involves blood tests like GGT and liver biopsy. Severe alcoholic hepatitis has high short-term mortality and is treated with corticosteroids or pentoxifylline to reduce inflammation. Prognosis can be predicted using scores like Maddrey DF and management involves lifestyle changes like abstaining from alcohol and adequate nutrition.
Spontaneous bacterial peritonitis (SBP) is an infection of ascitic fluid in people with liver cirrhosis and ascites. It is defined by a positive ascitic fluid culture with ≥250 PMN cells/mm3 in the absence of an intra-abdominal source. Risk factors include low ascitic fluid protein and prior SBP. Translocation of gut bacteria through the intestinal wall and lymphatics is a main mechanism. Treatment involves antibiotics like cefotaxime for 5-7 days. Prognosis depends on clinical stability, though prophylaxis may be considered for high risk patients.
Brief explanation of each *refer harrison textbook for details causes of TIN
Acute interstitial nephritis
Chronic interstitial nephritis
Reflux nephropathy
Papillary necrosis
Sickle-cell nephropathy
Notes complications of liver cirrhosis Prakash Prakh
Portal hypertension is a major complication of liver cirrhosis that can lead to serious issues like variceal hemorrhage and ascites. It is caused by increased resistance to blood flow within the liver and increased blood flow into the portal vein system. Variceal hemorrhage has a high mortality rate and ascites can become refractory to treatment, requiring interventions like TIPS or transplantation. Managing the complications of portal hypertension is challenging and important for patient outcomes.
This document provides information on the clinical management of a patient presenting with jaundice. It begins by defining jaundice and explaining bilirubin metabolism. Jaundice is classified by the type of circulating bilirubin (conjugated or unconjugated) and site of the problem (prehepatic, hepatocellular, or cholestatic/obstructive). The causes, clinical manifestations, appropriate laboratory tests, and imaging studies are described for each type of jaundice to aid in diagnosis and management. A thorough history, physical exam, and targeted lab and imaging workup are recommended to determine the underlying etiology causing a patient's jaundice.
The document discusses several cases of acute nephritic syndrome. It describes the typical presentation of nephritic syndrome including hematuria, proteinuria, hypertension, and renal dysfunction. It also discusses ways to classify glomerular diseases based on clinical syndrome, biochemical abnormalities, or histopathology. Several cases are presented and discussed in terms of etiology, diagnosis, and management based on lab results, serology, immune workup, and kidney biopsy findings where applicable. Conditions discussed include post-streptococcal glomerulonephritis, membranoproliferative glomerulonephritis, lupus nephritis, IgA nephropathy, rapidly progressive glomerulonephritis, and
Hematuria refers to the presence of blood in the urine. A diagnosis requires red blood cells to be present in urine samples obtained at least a week apart. Hematuria can be classified as microscopic or macroscopic, intermittent or persistent, and by its location in the urinary tract. Potential causes include glomerular disease, tumors, infections, vascular abnormalities, stones and trauma. Evaluation involves urinalysis, urine culture, imaging tests like ultrasound and CT urography, and cystoscopy depending on risk factors. Treatment focuses on the underlying cause if identified, while asymptomatic microscopic hematuria often requires monitoring without intervention.
Management Of Nephrotic Syndrome
Objectives
To briefly review the definition & etiology of nephroticsyndrome.
To understand the terminology pertaining to clinical course of nephroticsyndrome.
To understand the management of nephroticsyndrome:Specific management & Supportive care and management of complications
Management of congenital nephrotic syndrome
Mr. Saeed M. M. is a 73-year-old Saudi male who has a history of diabetes for 30 years and hypertension for 3 years. He presents with itching, bruising, swelling of the face and limbs, and vomiting for the past few weeks. He is known to have chronic kidney disease for the past 3 years. On examination, he has edema, ascites, and elevated creatinine. Laboratory tests show anemia, thrombocytopenia, and metabolic acidosis. He is diagnosed with end-stage renal disease and started on management including fluid restriction, medications, and education for future hemodialysis treatment.
This document provides an overview of hematuria and glomerular causes of hematuria. It defines macroscopic and microscopic hematuria and discusses various glomerular diseases that can cause hematuria including IgA nephropathy, Alport syndrome, thin basement membrane disease, post-infectious glomerulonephritis, and Henoch–Schönlein purpura. It describes the clinical presentations, pathologies, diagnoses, and treatments of these conditions. Key investigations for glomerular hematuria are outlined.
Chronic glomerulonephritis is a kidney disorder caused by slow, cumulative damage and scarring of the glomeruli, or tiny blood filters in the kidneys, usually due to inflammation. This results in reduced kidney function over time and can lead to chronic kidney disease, end-stage renal disease, cardiovascular disease, renal failure, and death if left untreated. Treatment focuses on slowing disease progression, managing symptoms like high blood pressure and fluid retention, and renal replacement therapy with dialysis or kidney transplantation for kidney failure.
1. The patient, a 48-year-old otherwise healthy woman, presented with microscopic hematuria on a routine urinalysis.
2. Microscopic hematuria is defined as more than 3 red blood cells per high-power field on urinalysis.
3. Evaluation of the patient with hematuria includes urine analysis, urine culture if indicated by presence of white blood cells, renal ultrasound or CT urogram, cystoscopy if lower urinary tract is suspected, and further testing depending on initial findings.
lupus nephritis is a autoimmune disease, commonly seen in adult and child and the medical or nursing care is also very important for this type of disease condition.
Minimal change disease is a kidney disorder that can lead to nephrotic syndrome. A nephrotic syndrome is a group of symptoms that include protein in the urine, low blood protein levels in the blood, high cholesterol levels, high triglyceride levels, and swelling.
Acute poststreptococcal glomerulonephritis (APSGN) is characterized by sudden edema, hematuria, proteinuria, and hypertension 1-4 weeks after a streptococcal infection. Histologically, there is diffuse proliferation of glomerular cells and leukocytes. It is caused by immune complexes forming in response to certain M protein serotypes of streptococcus. On microscopy, there are subepithelial immune deposits, complement activation, and inflammation, appearing as "humps". Patients typically experience malaise, fever, nausea, and hematuria after a sore throat. Laboratory findings include elevated antibody titers and low complement levels. Most children fully recover with conservative care, while a small percentage progress
A simple description of a less understood topic in Intensive Care Medicine. Aim to make understanding and management easy for the residents and prevention steps for all ICU workers.
This document provides guidelines for the evaluation and management of hematuria from the Department of Urology at Govt Royapettah Hospital and Kilpauk Medical College in Chennai. It discusses the classification, timing, differential diagnosis, and evaluation of hematuria. The evaluation includes history, physical exam, urinalysis, urine culture if indicated, renal function testing, cystoscopy, and imaging such as CT urogram. The goal of evaluation is to identify any underlying causes of hematuria such as infection or malignancy. Close follow up is recommended depending on the diagnosis and persistence of microscopic hematuria.
The document discusses acute kidney injury (AKI), including its causes, diagnosis, and management. It provides details on prerenal, intrinsic, and postrenal forms of AKI. For prerenal AKI, management focuses on correcting the underlying cause, such as volume depletion, and restoring intravascular volume through fluid resuscitation. For intrinsic AKI, identifying and removing nephrotoxic agents is important. Dialysis may be needed for severe AKI with fluid/electrolyte imbalance or uremia.
Dr. Sachin Verma is a young, diligent and dynamic physician. He did his graduation from IGMC Shimla and MD in Internal Medicine from GSVM Medical College Kanpur. Then he did his Fellowship in Intensive Care Medicine (FICM) from Apollo Hospital Delhi. He has done fellowship in infectious diseases by Infectious Disease Society of America (IDSA). He has also done FCCS course and is certified Advance Cardiac Life support (ACLS) and Basic Life Support (BLS) provider by American Heart Association. He has also done a course in Cardiology by American College of Cardiology and a course in Diabetology by International Diabetes Centre. He specializes in the management of Infections, Multiorgan Dysfunctions and Critically ill patients and has many publications and presentations in various national conferences under his belt. He is currently working in NABH Approved Ivy super-specialty Hospital Mohali as Consultant Intensivists and Physician.
Hematuria for undergraduates
this is a presentation i prepared for medical students about hematuria, hope u like it
for more urology resources visit:
www.uronotes2012.blogspot.com
This document discusses alcoholic liver disease (ALD). It notes that ALD ranges in severity from fatty liver to alcoholic hepatitis to cirrhosis. Risk factors include the amount of alcohol consumed daily and genetically. Diagnosis involves blood tests like GGT and liver biopsy. Severe alcoholic hepatitis has high short-term mortality and is treated with corticosteroids or pentoxifylline to reduce inflammation. Prognosis can be predicted using scores like Maddrey DF and management involves lifestyle changes like abstaining from alcohol and adequate nutrition.
Spontaneous bacterial peritonitis (SBP) is an infection of ascitic fluid in people with liver cirrhosis and ascites. It is defined by a positive ascitic fluid culture with ≥250 PMN cells/mm3 in the absence of an intra-abdominal source. Risk factors include low ascitic fluid protein and prior SBP. Translocation of gut bacteria through the intestinal wall and lymphatics is a main mechanism. Treatment involves antibiotics like cefotaxime for 5-7 days. Prognosis depends on clinical stability, though prophylaxis may be considered for high risk patients.
Brief explanation of each *refer harrison textbook for details causes of TIN
Acute interstitial nephritis
Chronic interstitial nephritis
Reflux nephropathy
Papillary necrosis
Sickle-cell nephropathy
Notes complications of liver cirrhosis Prakash Prakh
Portal hypertension is a major complication of liver cirrhosis that can lead to serious issues like variceal hemorrhage and ascites. It is caused by increased resistance to blood flow within the liver and increased blood flow into the portal vein system. Variceal hemorrhage has a high mortality rate and ascites can become refractory to treatment, requiring interventions like TIPS or transplantation. Managing the complications of portal hypertension is challenging and important for patient outcomes.
This document provides information on the clinical management of a patient presenting with jaundice. It begins by defining jaundice and explaining bilirubin metabolism. Jaundice is classified by the type of circulating bilirubin (conjugated or unconjugated) and site of the problem (prehepatic, hepatocellular, or cholestatic/obstructive). The causes, clinical manifestations, appropriate laboratory tests, and imaging studies are described for each type of jaundice to aid in diagnosis and management. A thorough history, physical exam, and targeted lab and imaging workup are recommended to determine the underlying etiology causing a patient's jaundice.
The document discusses several cases of acute nephritic syndrome. It describes the typical presentation of nephritic syndrome including hematuria, proteinuria, hypertension, and renal dysfunction. It also discusses ways to classify glomerular diseases based on clinical syndrome, biochemical abnormalities, or histopathology. Several cases are presented and discussed in terms of etiology, diagnosis, and management based on lab results, serology, immune workup, and kidney biopsy findings where applicable. Conditions discussed include post-streptococcal glomerulonephritis, membranoproliferative glomerulonephritis, lupus nephritis, IgA nephropathy, rapidly progressive glomerulonephritis, and
Hematuria refers to the presence of blood in the urine. A diagnosis requires red blood cells to be present in urine samples obtained at least a week apart. Hematuria can be classified as microscopic or macroscopic, intermittent or persistent, and by its location in the urinary tract. Potential causes include glomerular disease, tumors, infections, vascular abnormalities, stones and trauma. Evaluation involves urinalysis, urine culture, imaging tests like ultrasound and CT urography, and cystoscopy depending on risk factors. Treatment focuses on the underlying cause if identified, while asymptomatic microscopic hematuria often requires monitoring without intervention.
Management Of Nephrotic Syndrome
Objectives
To briefly review the definition & etiology of nephroticsyndrome.
To understand the terminology pertaining to clinical course of nephroticsyndrome.
To understand the management of nephroticsyndrome:Specific management & Supportive care and management of complications
Management of congenital nephrotic syndrome
Mr. Saeed M. M. is a 73-year-old Saudi male who has a history of diabetes for 30 years and hypertension for 3 years. He presents with itching, bruising, swelling of the face and limbs, and vomiting for the past few weeks. He is known to have chronic kidney disease for the past 3 years. On examination, he has edema, ascites, and elevated creatinine. Laboratory tests show anemia, thrombocytopenia, and metabolic acidosis. He is diagnosed with end-stage renal disease and started on management including fluid restriction, medications, and education for future hemodialysis treatment.
This document provides an overview of hematuria and glomerular causes of hematuria. It defines macroscopic and microscopic hematuria and discusses various glomerular diseases that can cause hematuria including IgA nephropathy, Alport syndrome, thin basement membrane disease, post-infectious glomerulonephritis, and Henoch–Schönlein purpura. It describes the clinical presentations, pathologies, diagnoses, and treatments of these conditions. Key investigations for glomerular hematuria are outlined.
Chronic glomerulonephritis is a kidney disorder caused by slow, cumulative damage and scarring of the glomeruli, or tiny blood filters in the kidneys, usually due to inflammation. This results in reduced kidney function over time and can lead to chronic kidney disease, end-stage renal disease, cardiovascular disease, renal failure, and death if left untreated. Treatment focuses on slowing disease progression, managing symptoms like high blood pressure and fluid retention, and renal replacement therapy with dialysis or kidney transplantation for kidney failure.
1. The patient, a 48-year-old otherwise healthy woman, presented with microscopic hematuria on a routine urinalysis.
2. Microscopic hematuria is defined as more than 3 red blood cells per high-power field on urinalysis.
3. Evaluation of the patient with hematuria includes urine analysis, urine culture if indicated by presence of white blood cells, renal ultrasound or CT urogram, cystoscopy if lower urinary tract is suspected, and further testing depending on initial findings.
lupus nephritis is a autoimmune disease, commonly seen in adult and child and the medical or nursing care is also very important for this type of disease condition.
Minimal change disease is a kidney disorder that can lead to nephrotic syndrome. A nephrotic syndrome is a group of symptoms that include protein in the urine, low blood protein levels in the blood, high cholesterol levels, high triglyceride levels, and swelling.
Acute poststreptococcal glomerulonephritis (APSGN) is characterized by sudden edema, hematuria, proteinuria, and hypertension 1-4 weeks after a streptococcal infection. Histologically, there is diffuse proliferation of glomerular cells and leukocytes. It is caused by immune complexes forming in response to certain M protein serotypes of streptococcus. On microscopy, there are subepithelial immune deposits, complement activation, and inflammation, appearing as "humps". Patients typically experience malaise, fever, nausea, and hematuria after a sore throat. Laboratory findings include elevated antibody titers and low complement levels. Most children fully recover with conservative care, while a small percentage progress
A simple description of a less understood topic in Intensive Care Medicine. Aim to make understanding and management easy for the residents and prevention steps for all ICU workers.
This document provides guidelines for the evaluation and management of hematuria from the Department of Urology at Govt Royapettah Hospital and Kilpauk Medical College in Chennai. It discusses the classification, timing, differential diagnosis, and evaluation of hematuria. The evaluation includes history, physical exam, urinalysis, urine culture if indicated, renal function testing, cystoscopy, and imaging such as CT urogram. The goal of evaluation is to identify any underlying causes of hematuria such as infection or malignancy. Close follow up is recommended depending on the diagnosis and persistence of microscopic hematuria.
Approach to Hematuria including:
Definition of Hematuria.
Pathophysiology of Hematuria.
Differential Diagnosis of Red Urine.
Causes of Hematuria.
Approach to a patient with Hematuria.
Diagnostic Algorithms.
Management and Disposition.
HELLO FRIENDS HERE CAUSES OF HEMATURIA IS HERE MANAGEMENT IN NEXT PRESENTATION ...YOU CAN SEE AND SUBSCRIBE OVER YOU TUBE ...LEARN UROLOGY IS CHANNEL NAME
FOLLOW THE YOU TUBE CHANNEL FOR FUTURE UROLOGY VIDEO
https://www.youtube.com/channel/UCINcUe475Y3c3BvXHvZ8wEw
This document discusses hematuria, or blood in the urine. It defines macroscopic and microscopic hematuria and describes how hematuria can be classified. Common causes of hematuria are discussed, including stones, infections, tumors, trauma, vascular issues, anatomical anomalies, and inherited conditions. Evaluation of hematuria involves urine analysis, urine culture, imaging like ultrasound or CT, and possible cystoscopy. Follow up is usually needed due to risk of underlying malignancy. Four case examples are presented.
This document summarizes significant hematologic lab tests used in dentistry, including complete blood count (CBC), erythrocyte sedimentation rate (ESR), and tests of haemostasis. It describes normal ranges and implications of abnormalities for various components of CBC, such as increased or decreased red blood cells, white blood cells, platelets, and differentials. Examples are given of hematologic conditions that can cause oral manifestations and bleeding risks, along with dental treatment precautions. Case studies demonstrate using lab results to diagnose anemias, bleeding disorders, infections, and leukemia.
Hematuria is one of the most common presentation in urology opds as well as general surgery opd. A surgeon should be well versed with how a case of Hematuria should be approached and how should it be managed effectively.
Prostate diseases are common among aging men. Benign prostatic hyperplasia (BPH) is a non-cancerous enlargement of the prostate that leads to urinary symptoms. BPH prevalence increases with age, affecting 20% of men aged 41-50 and over 80% of men aged 81-90. Treatment options for BPH include lifestyle changes, watchful waiting, medical therapy with alpha blockers or 5-alpha-reductase inhibitors, and surgical procedures like TURP. Prostate cancer is the second most common cancer in men. Screening includes a PSA test and digital rectal exam. Treatment depends on cancer risk and may include active surveillance, surgery, radiation, or hormone therapy.
Hematuria can be caused by many conditions affecting the kidneys and urinary tract. It is important to evaluate the patient based on symptoms, risk factors, physical exam, and lab/imaging tests to determine the etiology and develop a treatment plan. Gross or microscopic hematuria may indicate infections, cancers, stones, or glomerular diseases. Evaluation involves urinalysis, imaging like ultrasound or CT, and further tests based on findings. Goals of treatment are to ensure urine can drain, identify the cause, and provide follow-up care and management.
1. A 60-year-old woman presented with recurrent episodes of painless gross hematuria over the past year. Physical exam and labs were normal except urine cytology positive for malignant cells.
2. Cystoscopy showed normal bladder mucosa with no lesions or active bleeding.
3. CT urography revealed a mass in the left kidney concerning for renal cell carcinoma.
A 59-year-old male smoker presented with swelling of the lower limbs, difficulty breathing, and decreased urine output over the past month. Laboratory investigations showed renal failure with a creatinine of 10.3 mg/dL. He was admitted and started on daily hemodialysis. Further workup found a positive direct Coombs test, consistent with autoimmune hemolytic anemia. Over the hospital course, his renal function and anemia improved with hemodialysis and medications. A differential diagnosis included warm or cold type autoimmune hemolytic anemia from various underlying causes.
1. Hematuria, or blood in the urine, can be an early sign of urothelial cancer. Evaluation of hematuria involves classifying it as glomerular or non-glomerular, identifying risk factors, and discussing cost-effective diagnostic approaches.
2. Dipstick testing and microscopic examination are used to detect and classify hematuria. Cystoscopy and imaging studies may be used to identify the source and guide management.
3. Patients with gross hematuria or other risk factors like smoking have a higher likelihood of underlying urologic malignancy and warrant more thorough evaluation.
This document provides guidelines for evaluating potential renal transplant recipients and living kidney donors. For recipients, a thorough history, clinical exam, lab tests, imaging and biopsies are recommended to assess suitability and detect contraindications. Original kidney disease must be evaluated for risk of recurrence. For donors, standard criteria include age over 21, no infections, diseases, or malignancies. Donors require medical, lab and imaging exams as well as informed consent regarding risks. High risk donors like those with obesity, hypertension or hematuria may require further testing or be deemed unsuitable to donate.
This document provides guidelines for evaluating and managing hematuria (red blood cells in urine). It discusses:
1. The prevalence, causes, and differential diagnosis of hematuria depending on its origin from the glomerulus, kidneys, urologic structures, or adjacent organs.
2. The recommended evaluation of hematuria including a detailed history, physical exam, urine analysis, urine culture if infection is suspected, renal function tests, ultrasound, and cystoscopy.
3. The typical findings and management strategies for common hematuria causes like urinary tract infections (25%), malignancies (20%), and urinary stones (20%). Benign essential hematuria accounts for 15-20% and requires careful follow up
This document discusses several causes of hematuria (red blood cells in the urine) in children, including glomerular diseases like acute poststreptococcal glomerulonephritis and hemolytic uremic syndrome. Acute poststreptococcal glomerulonephritis typically occurs 1-2 weeks after a streptococcal infection and presents with edema, hypertension and hematuria. Hemolytic uremic syndrome is commonly caused by E. coli infection and presents with bloody diarrhea, decreased urination, anemia and thrombocytopenia. Both conditions can potentially lead to acute kidney injury and require careful fluid management and treatment of complications.
Hematuria in children can be detected by urinary dipstick or microscopic examination. Common causes include glomerular disease, hypercalciuria, and nutcracker syndrome. Evaluation depends on whether hematuria is isolated, accompanied by proteinuria, or symptomatic. For isolated hematuria, follow-up includes urine culture and screening for hypercalciuria if persistent. Hematuria with proteinuria warrants further testing including serum creatinine. Symptomatic hematuria evaluation includes history, physical exam, and urinalysis to determine glomerular vs extraglomerular cause. Renal biopsy is considered if hematuria is substantial or progressive.
Dr. Sanjay R.P. and Dr. Rajendra Prasad chaired a discussion on the evaluation and management of hematuria. Hematuria is defined as the presence of red blood cells in urine and can be classified based on intensity, origin, relation to urination, etiology, and associated symptoms. Evaluation involves a history and physical exam to determine the cause and guide appropriate testing such as urine analysis, cystoscopy, imaging studies. For microscopic hematuria, initial evaluation includes risk assessment for malignancy and medical renal disease to guide further urologic or nephrologic evaluation if needed.
This document discusses the evaluation of hematuria from the Department of Urology at Govt Royapettah Hospital and Kilpauk Medical College in Chennai. It defines hematuria and describes its classification. Potential causes of hematuria are outlined, including urinary tract infections, kidney stones, trauma, exercise, and tumors. The evaluation of hematuria involves examination of the urine, including a dipstick test and microscopic analysis to characterize the red blood cells. Further tests may include imaging like ultrasound, CT, cystoscopy and renal biopsy to identify the source and cause of the bleeding. The document distinguishes between glomerular and non-glomerular causes based on urine characteristics.
This document provides an overview of acute pancreatitis, including its definition, epidemiology, causes, signs and symptoms, diagnostic tests, treatment, and complications. It notes that acute pancreatitis results from inflammation of the pancreas that can range from mild to severe. Diagnostic testing includes blood tests, imaging like ultrasound, CT, and MRI to determine severity. Treatment involves supportive care, pain management, fluid resuscitation, and treating any underlying causes or complications like infection if they develop.
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
2. DEFINITIONS
• GROSS HEMATURIA : The presence of enough
blood in a urine sample to be visible to the naked
eye
• MICROSCOPIC HEMATURIA : The presence of 3 or
more RBCs per HPF on two or more properly
collected urinalyses
(AMH found in 9–18% of adults)
2
4. Case Scenario
• A 55-year-old male presents to your office for
evaluation of blood in his urine.
• It turns out that the urinalysis showed 2+
blood on urine dipstick and 2 RBC/hp .
• The remainder o the urinalysis and
microscopic examination was normal.
4
5. After an appropriate history and physical
examination, your first step in the evaluation of this
urine abnormality is to:
A) Repeat the urinalysis and microscopic examination.
B) Obtain urine or culture.
C) Order a renal ultrasound.
D) Order a C scan o the abdomen.
E) Order an intravenous pyelogram (IVP).
5
6. • The correct answer is “A.”
• According to the urinalysis, there is a small amount
of blood in your patient’s urine, but the number o
RBCs is actually normal (< 3 RBC/hp ).
• Your first step should be to repeat the urinalysis
and urine microscopic examination to determine if
this patient actually meets the criteria or
microscopic hematuria (≥ 3 RBC/hp on two of the
three properly collected urine specimens,
according to the American Urological Association).
6
7. • A urine culture may prove useful later in the
evaluation process but is not necessary now.
• Likewise, ordering imaging studies is
premature because the diagnosis of
microscopic hematuria has not been made.
7
8. • Further history reveals that he smokes one to two
packs of cigarettes per day.
• He has a normal blood pressure and the
remainder o the physical examination is
unrevealing.
• On two urine samples, you find microscopic
hematuria, with a positive dipstick and 5 RBC/hp .
• The rest of the urinalysis is normal, and there are
no red cell casts.
8
9. In your evaluation o this patient, you include all of
the following tests EXCEPT:
A) Urine cytology.
B) CBC.
C) Serum creatinine.
D) CT scan of the abdomen and pelvis with
particular note of the kidneys.
E) Renal biopsy.
9
10. • The correct answer is “E.”
• In most cases of microscopic hematuria, renal
biopsy is not indicated.
• However, if an intrinsic renal cause of
hematuria is suspected, renal biopsy may
prove necessary.
10
11. Intrinsic renal disease is more likely if there is
proteinuria, hypertension, elevated serum
creatinine, or an active urinary sediment (e.g.,
nephritic, dysmorphic red cells, red cell casts).
11
12. • There is no completely standardized evaluation
of microscopic hematuria, and
recommendations vary depending on the author.
• However, the recommendations always include
serum creatinine and usually include CBC,
coagulation studies, and serum chemistries.
• Depending on the patient’s age, further studies
may be indicated
12
13. • For patients older than 40 years, you should
consider studies to evaluate or urinary tract
cancers.
• Urine cytology has low sensitivity but high
specificity or bladder cancer and may be quite
useful in conjunction with cystoscopy.
• Imaging of the urinary system is an absolute
requirement in the work-up o microscopic
hematuria in older patients (generally, those
over age 40 years).
13
14. • CT scan appears to have the greatest sensitivity
or detecting masses, but ultrasound, IVP, or the
combination of the two may also be employed.
• Cystoscopy should be considered if the CT scan
is normal since CT is poor at visualizing bladder
abnormalities.
14
15. The US Preventive Services Task Force
recommends which o the following screening
strategies or detecting microscopic hematuria?
A) Annual urinalysis af er age 50.
B) Urinalysis every 2 years af er age 50.
C) Annual urinalysis af er age 65.
D) Annual urinalysis in all high-risk patients older
than 65 years.
E) No screening at any age.
15
16. • The correct answer is “E.”
• The USPS F recommends against routine
screening or microscopic hematuria to detect
urinary tract cancers.
• In one-time urine specimens in healthy adults,
the presence of abnormal numbers o RBCs (≥ 3
RBCs/hp ) can be as high as 39%.
• In up to 70% of patients, even after imaging of
the upper and lower urinary tract, the source of
microscopic hematuria cannot be found. 16
17. • In a low-risk population, the false-positive rate of
microscopic hematuria found on urinalysis would
be unacceptably high.
• Also, there is no evidence that early detection of
urinary tract cancers through screening urinalysis
improves prognosis.
17
18. History
• Transient vs. persistent
hematuria
• Fevers
• Pain
• Medications,
• Trauma
• Pyuria
• Dysuria
• blood clots
18
• Lower urinary tract symptoms
• Recent URI (postinfectious
glomerulonephritis/IgA
nephropathy) or sexual activity
• Personal/family history of
renal disease
• Malignancy
• Bleeding disorders
• Occupational exposures
• Travel hx
Ann Int Med 2016;164:488
JAMA 2016;315:2726
NEJM 2003;348:2330
19. • Medications & food associated with red urine:
Rifampin, phenazopyridine, iron sorbitol,
nitrofurantoin, chloroquine; rarely beets,
blackberry, rhubarb, food coloring
• Medications associated with Hematuria:
Aminoglycosides, amitriptyline, analgesics,
anticonvulsants, ASA, diuretics, OCPs, penicillins
(extended spectrum), warfarin
19
AFP 2006;73:1748
29. Evaluation of AMH
After microscopic hematuria has been identified
(2 of 3 urine samples with 3 or more RBC/hpf),
the American Urological Association (AUA)
recommends the following evaluation:
29
30. • Infection identified treat with antibiotics
and repeat urinalysis after 6 weeks
• RBC casts, proteinuria, or elevated creatinine
begin evaluation for glomerulonephritis and
consider referral to a nephrologist
30
31. • No infection or primary renal disease identified in
first 2 steps
- CT scan (contrast ?)
- bladder cystoscopy (if at risk for bladder cancer
based on environmental exposures and/or age >
40)
31
32. If entire thorough diagnostic
evaluation negative follow-
up urinalysis, urine cytology,
blood pressure, and serum
creatinine every 6-12 months
32
33. Cytology ?
• Cannot r/o bladder Ca (Se 40–76%)
• But ⊕ cytology diagnostic of urothelial Cancer
• NOT recommended as part of routine evaluation
of AMH
• May be useful if workup otherwise ⊖
33
34. Take home message
• Hematuria in adults should always be
evaluated.
• If no source is found on a thorough initial
workup, patients should be followed for at
least 3 years to monitor for an underlying
condition.
• In every case of a first-time microscopic
hematuria, a repeat urinalysis with
microscopy is required at 6-week interval
before any other management is done.
34
36. References
• Cohen RA, Brown RS. Microscopic hematuria. N Engl]
Med. 2003;348:2330-2338.
• Davis RJ, Jones S, Barocas DA, et al. Diagnosis,
evaluation and follow-up of asymptomatic
microhematuria (AMH) in adults: AUA guideline. 2012.
American Urological Association.
• Grossfeld GD, Litwin MS, Wolf JS, et al. Evaluation of
asymptomatic microscopic hematuria in adults: the
American Urological Association best practice policy-
part I: definition, detection, prevalence, and etiology.
Urology. 2001;57( 4):599-603.
• O'Connor OJ, McSweeney SE, Maher MM. Imaging of
hematuria. Radiol Clin North Am. 2008;46:113.
36
37. • A 60-year-old man with past medical history
of BPH presents to you with gross hematuria
for 1 day.
• He states this has never happened before and
denies strenuous exercise.
• Upon further questioning he does reveal that
2 days ago he had a bladder catheterization to
evaluate his postvoid residual.
• He denies smoking, family history of cancers,
or chemical exposures.
• Which of the following is the most appropriate
management at this time? 37
38. A. Counsel the patient on the high likelihood of gross
hematuria after a urologic procedure and that this
will likely subside. Let him know no test is required
today.
B. Do a urine dipstick first. If positive then proceed
to urinalysis with microscopy and have the patient
return in a few weeks for a repeat UA with
microscopy.
C. Discuss with the patient the high likelihood of
malignancy with gross hematuria especially given his
age and past history and recommend imaging upper
and lower urinary tracts.
D. Tell him that he likely needs urine cytology today
to rule out malignancy.
38
39. • A 54-year-old postmenopausal woman with
past medical history of hypertension is
incidentally found to have significant
microscopic hematuria on a UA that was done
as part of her annual hypertension laboratory
tests.
• She denies dysuria, gross hematuria, fevers,
chills, and nausea/vomiting.
• Her physical examination is negative for
suprapubic tenderness and flank pain.
• What would be the next best step in the
management of this patient?
39
40. A. Repeat UA with microscopy in 3 months at her next
follow-up visit for hypertension.
B. Perform a urine culture and if positive, treat
immediately. Repeat UA posttreatment.
C. Order renal function testing to rule out medical
renal disease as an etiology.
D. Repeat UA with microscopy in 6 weeks.
40
41. • A 65-year-old man with past medical history of
hypertension, coronary artery disease, chronic kidney
disease (CKD), and a pacemaker presents to your office
with complaint of “dark urine” for many weeks now.
• He states he has been evaluated by several other
physicians who had done "several tests“ that all came
back negative.
• He states he has never had any imaging done and would
like you to "take a look at what is going on in there”
• Upon accessing his medical records you see that he has
already had several UA with microscopy that were all
positive for microscopic hematuria, renal function testing,
which is significant for elevated BUN and creatinine and
decreased GFR, and negative urine cultures.
• At this time, what would be the most appropriate imaging
modality and management for this patient? 41
42. A. Counsel the patient against imaging at this time as
any imaging may worsen his CKD.
B. Order magnetic resonance urography (MRU) as
the patient is unable to undergo CT urography given
his renal insufficiency, along with an urgent urology
referral.
C. Order a combined renal ultrasound and
retrograde pyelogram for maximum visualization of
upper urinary tract, along with an urgent urology
referral.
D. Order urine cytology and urine markers as these
are the least invasive test of choice at this time.
42